Bioorganic & medicinal chemistry letters

Novel, Potent Non-Covalent Thrombin Inhibitors Incorporating P 3-Lactam Scaffolds

JZ Ho, TS Gibson, JE Semple

Index: Ho, Jonathan Z.; Gibson, Tony S.; Semple Bioorganic and Medicinal Chemistry Letters, 2002 , vol. 12, # 5 p. 743 - 748

Full Text: HTML

Citation Number: 30

Abstract

Evolution of P1-argininal inhibitor prototypes led to a series of non-covalent P3-7-membered lactam inhibitors 1a–w, featuring novel peptidomimetic units that probe each of the S1, S2, and S3 specificity pockets of thrombin. Rigid P1-arginine surrogates possessing a wide range of basicity (calcd pKa's∼ neutral–14) were surveyed. The design, synthesis, and biological activity of these targets are presented.

Related Articles:

Efficacious and orally bioavailable thrombin inhibitors based on a 2, 5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl [(5- …

[Journal of Medicinal Chemistry, , vol. 46, # 17 p. 3612 - 3622]

Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor Xa

[Journal of Medicinal Chemistry, , vol. 42, # 18 p. 3557 - 3571]

Noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1

[Bioorganic and Medicinal Chemistry Letters, , vol. 12, # 7 p. 1017 - 1022]

Noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1

[Bioorganic and Medicinal Chemistry Letters, , vol. 12, # 7 p. 1017 - 1022]

Novel, Potent Non-Covalent Thrombin Inhibitors Incorporating P 3-Lactam Scaffolds

[Bioorganic and Medicinal Chemistry Letters, , vol. 12, # 5 p. 743 - 748]

More Articles...